Genetic data do not provide evidence that lower sclerostin is associated with increased risk of atherosclerosis: comment on the article by Zheng et al
Arthritis Rheumatol
.
2023 Nov 9.
doi: 10.1002/art.42751.
Online ahead of print.
Authors
James R Staley
1
,
Olga Giannakopoulou
1
,
Gill Holdsworth
1
,
Martin Armstrong
2
Affiliations
1
UCB Pharma, Slough, UK.
2
UCB Pharma, Braine-L'Alleud, Belgium.
PMID:
37942677
DOI:
10.1002/art.42751
No abstract available
Publication types
Letter
Grants and funding
Amgen
UCB Celltech